LLY


Eli Lilly’s Bebtelovimab Bags FDA Emergency Use Approval

This article was originally published on TipRanks.com American pharmaceutical company Eli Lilly and Company’s (NYSE: LLY) COVID-19 antiviral treatment, bebtelovimab, has received authorization for …

Eli Lilly Drops 2.4% Despite Beating Q4 Expectations

This article was originally published on TipRanks.com American healthcare and drug manufacturer Eli Lilly and Co.

Lilly to Invest $1 Billion in North Carolina; Shares Rise 3.5%

This article was originally published on TipRanks.com Pharmaceutical corporation Eli Lilly and Company (NYSE: LLY) recently announced that it is looking to invest $1 billion to develop …

Eli Lilly Inks Collaboration Deal with Abbisko

This article was originally published on TipRanks.com Eli Lilly and Company (NYSE: LLY) has signed a worldwide collaboration and exclusive licensing agreement with Abbisko Therapeutics Co.

Eli Lilly Impresses at Investment Community Meeting

This article was originally published on TipRanks.com Shares of the global healthcare company, Eli Lilly and Company (LLY) reached a new all-time high …

Eli Lilly Partners with Foghorn; Shares Pop

This article was originally published on TipRanks.com Loxo Oncology, the research and development group of Eli Lilly and Company (NYSE: LLY) has signed a strategic collaboration agreement with Foghorn …

Lilly & Regor Therapeutics to Collaborate on Metabolic Disorder Therapies

This article was originally published on TipRanks.com Pharmaceutical corporation Eli Lilly and Company (LLY) recently announced that it has entered into a multi-year research collaboration and …

Eli Lilly Receives Emergency Use Nod for COVID-19 Antibody Therapy in Patients Under Age 12

This article was originally published on TipRanks.com Eli Lilly and Company’s (LLY) antibody treatment has received expanded Emergency Use Authorization from the U.

Eli Lilly’s Q3 Earnings Miss but Revenues Beat Estimates

American pharmaceutical company Eli Lilly and Company (LLY) has posted lower-than-expected earnings for the third quarter of 2021. However, revenues surpassed analysts’ expectations …

Eli Lilly And Incyte’s Baricitinib Fails To Meet Endpoint In Phase 3 COVID-19 Trial

Eli Lilly and Co. And Incyte reported data from their phase 3 study of baricitinib in hospitalized COVID-19 patients.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts